Lek d.d., PE Proizvodnja Lendava LEK Pharmaceuticals d.d. Novartis Pharma GmbH Salutas Pharma GmbH

The medicine is used in adults and children for the treatment of, among others, chronic myeloid leukemia, Philadelphia chromosome-positive acute lymphoblastic leukemia, myelodysplastic/myeloproliferative syndromes, hypereosinophilic syndrome, chronic eosinophilic leukemia, gastrointestinal stromal tumors (GIST), and dermatofibrosarcoma protuberans (DFSP).

Dosage form: tablets, film-coated

ATC: L01EA01